Fine-Tuning Risk Stratification in Heart Failure: Does It Improve Patient Care?
- PMID: 37052547
- DOI: 10.1016/j.jchf.2023.02.004
Fine-Tuning Risk Stratification in Heart Failure: Does It Improve Patient Care?
Keywords: IGFBP7; biomarker; heart failure; risk.
Conflict of interest statement
Funding Support and Author Disclosures Dr Omland has received consulting and/or speaker honoraria from Abbott Diagnostics, CardiNor, and Roche Diagnostics; and has received research support from AstraZeneca, Abbott Diagnostics, Novartis, and Roche Diagnostics through Akershus University Hospital. Dr Myhre has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure.JACC Heart Fail. 2023 Jun;11(6):662-674. doi: 10.1016/j.jchf.2023.01.016. Epub 2023 Apr 12. JACC Heart Fail. 2023. PMID: 37286261
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
